NCT00658957View on ClinicalTrials.gov

Prevention of Infection Using a Topical Gentamicin-Collagen Sponge in Diabetic Patients With An Uninfected Foot Ulcer

PHASE2TerminatedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Diabetic Foot Ulcer
Interventions
DRUG

gentamicin-collagen sponge

5 × 5 cm sponge

DRUG

placebo collagen sponge

5 × 5 cm sponge

Trial Locations (1)

21122

Chesapeake Foot and Ankle Center, Pasadena

Sponsors

Lead Sponsor

Innocoll
All Listed Sponsors
collaborator

Premier Research Group plc

UNKNOWN

lead

Innocoll

INDUSTRY

NCT00658957 - Prevention of Infection Using a Topical Gentamicin-Collagen Sponge in Diabetic Patients With An Uninfected Foot Ulcer | Biotech Hunter | Biotech Hunter